49 QUESTION WHEN SHOULD I CONSIDER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR RETINOPATHY OF PREMATURITY? Yoshihiro Yonekawa, MDKimberly A. Drenser, MD, PhD Retinopathy of prematurity (ROP) is a vascular endothelial…
11 QUESTION WHAT VISUALIZATION AGENTS ARE USED DURING VITRECTOMY SURGERY? AND WAIT, TELL ME ABOUT THE INTRAOCULAR TAMPONADE OPTIONS! Sean M. Platt, MDSophie J. Bakri, MD Visualization Agents The use…
48 QUESTION I SAW SOME RETINAL NEOVASCULARIZATION BUT MY PATIENT DOES NOT HAVE DIABETES, SO WHAT ELSE CAN IT BE? Brian E. Goldhagen, MD While diabetes is certainly the most…
47 QUESTION HOW LONG SHOULD I WAIT TO PERFORM CATARACT SURGERY AFTER TREATMENT OF DIABETIC MACULAR EDEMA OR RETINOPATHY? Linda A. Lam, MD, MBA A frequent dilemma for cataract surgeons…
46 QUESTION HOW DO I FOLLOW A PATIENT WHO HAS DIABETES AND BECOMES PREGNANT? WHAT TESTS CAN I DO? Judy E. Kim, MDAlessa Crossan, MD Pregnancy complicates the ophthalmic management…
42 QUESTION WHAT RETINAL FINDINGS SHOULD BE TREATED BEFORE CATARACT SURGERY, REFRACTIVE SURGERY, OR YTTRIUM-ALUMINUM-GARNET LASER? Franco M. Recchia, MD The goal of prophylactic retinal treatment is to reduce the…
41 QUESTION WHAT SYSTEMIC CONDITIONS ARE ASSOCIATED WITH AN INCREASED RISK OF RETINAL DETACHMENT? WHAT SHOULD I DO ABOUT IT? Joseph N. Martel, MDMallika Doss, MD The risk of rhegmatogenous…
37 QUESTION WHAT SHOULD I TELL A PATIENT WITH RETINITIS PIGMENTOSA ABOUT PROGNOSIS AND SHOULD I PRESCRIBE VITAMIN A OR OTHER SUPPLEMENTS? Jackson Abou Chehade, MDRaymond Iezzi, MD, MS Retinitis…
36 QUESTION WHEN SHOULD CATARACT SURGERY BE PERFORMED IF A VITRECTOMY IS PLANNED—BEFORE, DURING, OR AFTER? Michael I. Seider, MDAmar Patel, MD There are many factors to consider when deciding…
22 QUESTION HOW DO I WORK UP AND MANAGE A PATIENT WITH A VITREOUS HEMORRHAGE? Pauline T. Merrill, MDMarina Gilca, MD When evaluating a patient with a vitreous hemorrhage, the…
